首页> 外文期刊>Genetic testing and molecular biomarkers >Identification of Expanded Alleles of the FMR1 Gene Among High-Risk Population in Indonesia by Using Blood Spot Screening
【24h】

Identification of Expanded Alleles of the FMR1 Gene Among High-Risk Population in Indonesia by Using Blood Spot Screening

机译:利用血斑筛查鉴定印度尼西亚高危人群中FMR1基因的扩展等位基因

获取原文
获取原文并翻译 | 示例
       

摘要

The prevalence of Fragile X Syndrome (FXS) is 1 in 4000 in males and 1 in 2500 in males and females, respectively, in the general population. Several screening studies aimed at determining the prevalence of FXS have been conducted in individuals with intellectual disabilities (IDs) with a prevalence varying from 1.15% to 6.3% across different ethnic groups. A previous study in Indonesia showed an FXS prevalence of 1.9% among the ID population. A rapid, effective, and inexpensive method for FMR1 screening, using dried blood spots capable of detecting an expanded FMR1 allele in both males and females, was recently reported. We used this approach to screen 176 blood spots, collected from Central Java, Indonesia, for the presence of expanded FMR1 gene alleles. Samples were collected from high-risk populations: 112 individuals with ID, 32 obtained from individuals with diagnosis of autism spectrum disorders, and 32 individuals with a known family history of FXS. Fourteen subjects carrying an FMR1 expanded allele were identified including 7 premutations (55-200 CGG repeats) and 7 full mutations (> 200 repeats). Of the seven subjects identified with a full mutation, one subject was from a non-fragile X family, and six from were families with a history of FXS.
机译:在普通人群中,脆性X综合征(FXS)的患病率分别为男性中每4 000人中有1人,男性和女性中2500人中有1人。在智障人士中进行了几项旨在确定FXS患病率的筛查研究,不同种族人群的患病率从1.15%到6.3%不等。印度尼西亚先前的一项研究表明,流离失所者中的FXS患病率为1.9%。最近报道了一种快速,有效,廉价的FMR1筛查方法,该方法使用干血斑能够检测雄性和雌性中扩展的FMR1等位基因。我们使用这种方法筛选了从印度尼西亚中爪哇省收集到的176个血斑,其中存在扩展的FMR1基因等位基因。从高风险人群中收集样本:112名ID个体,32名自闭症谱系障碍诊断者和32名具有FXS家族史的个体。确定了十四名携带FMR1扩展等位基因的受试者,包括7个预突变(55-200个CGG重复)和7个完整突变(> 200个重复)。在确定为完全突变的7名受试者中,一名受试者来自非脆弱X族,六名来自具有FXS病史的家族。

著录项

  • 来源
    《Genetic testing and molecular biomarkers》 |2012年第3期|p.162-166|共5页
  • 作者单位

    Division of Human Genetic Center for Biomedical Research, Faculty of Medicine, Diponegoro University, Semarang, Indonesia;

    Division of Human Genetic Center for Biomedical Research, Faculty of Medicine, Diponegoro University, Semarang, Indonesia;

    Division of Human Genetic Center for Biomedical Research, Faculty of Medicine, Diponegoro University, Semarang, Indonesia;

    Departments of Biochemistry and Molecular Medicine and School of Medicine, University of California, Davis, Sacramento, California;

    Public Health Sciences, School of Medicine, University of California, Davis, Sacramento, California;

    Division of Human Genetic Center for Biomedical Research, Faculty of Medicine, Diponegoro University, Semarang, Indonesia;

    Departments of Biochemistry and Molecular Medicine ,MIND Institute, University of California, Davis, Sacramento, California.,Department of Biochemistry and Molecular Medicine School of Medicine University of California, Davis One Shields Ave. Davis, CA 95616;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 13:18:49

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号